Compound sixty has a very superior affinity to MDM2 (Ki < one nM), powerful cellular activity, and a very good oral pharmacokinetic profile. Compound 60 is able to reaching complete and long-Long lasting tumor regression in vivo which is at present in phase I scientific trials for most cancers pr